Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds
Makhaeva, Galina F.; Rudakova, Elena V.; Hein, Nichole D.; Serebryakova, Olga G.; Kovaleva, Nadezhda V.; Boltneva, Natalia P.; Fink, John K.; Richardson, Rudy J.
2014-12
Citation
Makhaeva, Galina F.; Rudakova, Elena V.; Hein, Nichole D.; Serebryakova, Olga G.; Kovaleva, Nadezhda V.; Boltneva, Natalia P.; Fink, John K.; Richardson, Rudy J. (2014). "Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds." Journal of Applied Toxicology 34(12): 1426-1435.
Abstract
Inhibition and aging of neuropathy target esterase (NTE) by neuropathic organophosphorus (OP) compounds triggers OP compound‐induced delayed neuropathy (OPIDN), whereas inhibition of acetylcholinesterase (AChE) produces cholinergic toxicity. The neuropathic potential of an OP compound is defined by its relative inhibitory potency toward NTE vs. AChE assessed by enzyme assays following dosing in vivo or after incubations of direct‐acting compounds or active metabolites with enzymes in vitro . The standard animal model of OPIDN is the adult hen, but its large size and high husbandry costs make this species a burdensome model for assessing neuropathic potential. Although the mouse does not readily exhibit clinical signs of OPIDN, it displays axonal lesions and expresses brain AChE and NTE. Therefore, the present research was performed as a further test of the hypothesis that inhibition of mouse brain AChE and NTE could be used to assess neuropathic potential using mouse brain preparations in vitro or employing mouse brain assays following dosing of OP compounds in vivo . Excellent correlations were obtained for inhibition kinetics in vitro of mouse brain enzymes vs. hen brain and human recombinant enzymes. Furthermore, inhibition of mouse brain AChE and NTE after dosing with OP compounds afforded ED 50 ratios that agreed with relative inhibitory potencies assessed in vitro . Taken together, results with mouse brain enzymes demonstrated consistent correspondence between in vitro and in vivo predictors of neuropathic potential, thus adding to previous studies supporting the validity of a mouse model for biochemical assessment of the ability of OP compounds to produce OPIDN. Copyright © 2014 John Wiley & Sons, Ltd. Although the mouse does not readily exhibit clinical signs of organophosphorus compound‐induced delayed neurotoxicity (OPIDN), it displays axonal lesions and expresses brain acetylcholinesterase (AChE) and neuropathy target esterase (NTE). The present research was performed as a further test of the hypothesis that inhibition of mouse brain AChE and NTE could be used to assess OPIDN potential using mouse brain preparations in vitro or employing mouse brain assays following dosing of OP compounds in vivo . Our results support this hypothesis.Publisher
North Holland Wiley Periodicals, Inc.
ISSN
0260-437X 1099-1263
Other DOIs
Types
Article
Metadata
Show full item recordCollections
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.